PI3K/AKT pathway has been confirmed by multiple studies in the development of multiple human cancers, and several clinical trials have confirmed that inhibiting the activity of PI3K/AKT pathway can inhibit the proliferation of tumor cells [21]. Here, AKT1 is linked to neoplasm.